Viral load, antibody titers and recombinant open reading frame 2 protein-induced Th1/Th2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e

Intervirology

Volumn 52, Issue 2, 2009, Pages 78-85

  Saravanabalaji, S ^a   Tripathy, A S ^a   Dhoot, R R ^b   Chadha, M S ^a   Kakrani, A L ^b   Arankalle, V A ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

^b B J MEDICAL COLLEGE   (India)

Author keywords

Antibody titers; Cytokines; Hepatitis E virus; Viral load

Indexed keywords

GAMMA INTERFERON; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT OPEN READING FRAME 2 PROTEIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; CYTOKINE; HEPATITIS ANTIBODY; ORF2 PROTEIN, HEPATITIS E VIRUS;

ADULT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VIRUS CELL INTERACTION; VIRUS LOAD; BLOOD; CELL PROLIFERATION; IMMUNOLOGY; INDIA; LYMPHOCYTE; MIDDLE AGED; PREGNANCY; SECRETION;

HEPATITIS E VIRUS;

ADULT; CELL PROLIFERATION; CYTOKINES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INDIA; LYMPHOCYTES; MALE; MIDDLE AGED; PREGNANCY; VIRAL LOAD; VIRAL PROTEINS; YOUNG ADULT;

EID: 65449184588     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214862     Document Type: Article

References (23)

1. Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH: Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci USA 1994;91:3428-3432.
2. Arankalle VA, Chobe LP, Jha J, Chadha MS, Banerjee K, Favorov MO, Kalinina T, Fields H: Aetiology of acute sporadic non-A, non-B viral hepatitis in India. J Med Virol 1993;40:121-125.
3. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI: Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252-255.
4. Chadha MS, Mehendale M, Arankalle VA, Athalye K, Banerjee K: Water supply schemes and enteric transmitted non-A non-B hepatitis epidemics: an experience in Khadakwasla village of Pune district. Ind J Comm Med 1991;16:153-158.
5. Arankalle VA, Jha J, Favorov MO, Chaudhari A, Fields HA, Banerjee K: Contribution of HEV and HCV in causing fulminant nonA, non-B hepatitis in western India. J Viral Hepat 1995;2:189-193.
6. Khuroo MS, Kamili S: Aetiology and clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61-69.
7. Acharya SK, Dasarathy S, Kumar TL, Sushma S, Uma Prasanna KS, Tandon A, Sreenivas V, Nijhawan S, Panda SK, Nanda SK, Irshad M, Joshi YK, Duttagupta S, Tandon RK, Tandon BN: Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology 1996;23:1448-1455.
8. Bernuau J, Rueff B, Benhamou JP: Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
9. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.
10. Bernal W: Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003;23:227-237.
11. Trey C, Davidson CS: The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-298.
12. Arankalle VA, Lole KS, Deshmukh TM, Chobe LP, Gandhe SS: Evaluation of human (genotype-1) and swine (genotype-4)-ORF-2 based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type-4 human HEV infections. J Viral Hepat 2007;14:435-445.
13. Gandhe SS, Chadha MS, Walimbe AM, Arankalle VA: Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat 2003;10:367-382.
14. Bukh J, Purcell RH, Miller RH: Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 1992;89:187-191.
15. Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US: Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 2009;27:1032-1039.
16. Tripathy A, Balaji SS, Rao N, Thakare J, Mishra A, Arankalle VA: Cytokine levels in Chandipura virus associated encephalopathy in children. Scand J Infect Dis 2005;37:590-593.
17. Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA: Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 2007;25:4350-4360.
18. Chadha MS, Walimbe AM, Chobe LP, Arankalle VA: Comparison of etiology of sporadic acute and fulminant viral hepatitis in hospitalized patients in Pune, India during 1978-1981 and 1994-1997. Indian J Gastroenterol 2003;22:11-15.
19. Arankalle VA, Chadha MS, Dama BM, Tsarev SA, Purcell RH, Banerjee K: Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998;5:199-204.
20. Arankalle VA, Chadha MS, Banerjee K, Srinivasan MA, Chobe LP: Hepatitis E virus infection in pregnant rhesus monkeys. Indian J Med Res 1993;97:4-8.
21. Suzuki K, Aikawa T, Okamoto H: Fulminant hepatitis E in Japan. N Engl J Med 2002;347:1456.
22. Tripathy A, Chadha MS, Arankalle VA: Cytokine profiles in peripheral blood mononuclear cells and sera from patients with acute self-limited hepatitis A. Acta Virol 2005;49:283-284.
23. Kawakami M, Tohyama M, Xie Q, Saito A: IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996;104:208-214.